Natus Medical Incorporated (BABY) Holdings Boosted by Virginia Retirement Systems ET AL
Virginia Retirement Systems ET AL boosted its holdings in Natus Medical Incorporated (NASDAQ:BABY) by 122.3% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 26,900 shares of the medical equipment provider’s stock after buying an additional 14,800 shares during the quarter. Virginia Retirement Systems ET AL owned 0.08% of Natus Medical worth $1,003,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. BlackRock Inc. raised its position in Natus Medical by 137,510.8% in the 1st quarter. BlackRock Inc. now owns 4,124,195 shares of the medical equipment provider’s stock worth $161,874,000 after buying an additional 4,121,198 shares during the last quarter. Ameritas Investment Partners Inc. purchased a new position in Natus Medical in the 1st quarter worth about $110,000. Kennedy Capital Management Inc. raised its position in Natus Medical by 12.9% in the 1st quarter. Kennedy Capital Management Inc. now owns 316,253 shares of the medical equipment provider’s stock worth $12,413,000 after buying an additional 36,151 shares during the last quarter. State of Alaska Department of Revenue raised its position in Natus Medical by 1.7% in the 1st quarter. State of Alaska Department of Revenue now owns 3,630 shares of the medical equipment provider’s stock worth $142,000 after buying an additional 60 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in Natus Medical by 4.8% in the 1st quarter. Vanguard Group Inc. now owns 2,274,870 shares of the medical equipment provider’s stock worth $89,289,000 after buying an additional 105,008 shares during the last quarter. 92.65% of the stock is owned by institutional investors and hedge funds.
In other Natus Medical news, Director William M. Moore sold 3,000 shares of the firm’s stock in a transaction dated Monday, August 14th. The stock was sold at an average price of $34.10, for a total value of $102,300.00. Following the completion of the sale, the director now owns 30,410 shares of the company’s stock, valued at $1,036,981. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider James B. Hawkins purchased 4,000 shares of the stock in a transaction on Thursday, June 15th. The stock was acquired at an average cost of $33.98 per share, with a total value of $135,920.00. Following the acquisition, the insider now owns 578,023 shares of the company’s stock, valued at approximately $19,641,221.54. The disclosure for this purchase can be found here. 5.50% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY WARNING: “Natus Medical Incorporated (BABY) Holdings Boosted by Virginia Retirement Systems ET AL” was reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.dailypolitical.com/2017/09/04/natus-medical-incorporated-baby-holdings-boosted-by-virginia-retirement-systems-et-al.html.
Natus Medical Incorporated (BABY) opened at 34.20 on Monday. The stock has a market cap of $1.11 billion, a price-to-earnings ratio of 59.27 and a beta of 0.96. The firm has a 50-day moving average price of $34.86 and a 200-day moving average price of $36.28. Natus Medical Incorporated has a 12 month low of $31.65 and a 12 month high of $44.39.
Natus Medical (NASDAQ:BABY) last issued its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.33 by $0.01. The business had revenue of $122.20 million during the quarter, compared to the consensus estimate of $121.99 million. Natus Medical had a return on equity of 12.09% and a net margin of 4.20%. The company’s quarterly revenue was up 27.3% on a year-over-year basis. During the same quarter last year, the company earned $0.39 earnings per share. Equities research analysts expect that Natus Medical Incorporated will post $1.70 earnings per share for the current fiscal year.
A number of equities analysts have weighed in on the company. BidaskClub lowered Natus Medical from a “sell” rating to a “strong sell” rating in a research report on Thursday, August 24th. Zacks Investment Research lowered Natus Medical from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $45.00.
Natus Medical Company Profile
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.